TipRanks
Acadia Healthcare (IT:1ACHC)
:1ACHC
Italy Market
1ACHC
Acadia Healthcare
RESEARCH TOOLSreports

Acadia Healthcare (1ACHC) Stock Forecast & Price Target

2 Followers
See the Price Targets and Ratings of:

1ACHC Analyst Ratings

Moderate Buy
10Ratings
Moderate Buy
6 Buy
3 Hold
1 Sell
Based on 10 analysts giving stock ratings to
Acadia
Healthcare
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

1ACHC Stock 12 Month Forecast

Average Price Target

€30.83
▲(25.33% Upside)
Based on 10 Wall Street analysts offering 12 month price targets for Acadia Healthcare in the last 3 months. The average price target is €30.83 with a high forecast of €34.90 and a low forecast of €26.18. The average price target represents a 25.33% change from the last price of €24.60.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"10":"€10","35":"€35","16.25":"€16.25","22.5":"€22.5","28.75":"€28.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":34.9027956,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€34.90</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":30.830802780000006,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€30.83</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":26.1770967,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€26.18</span>\n  </div></div>","useHTML":true}}],"tickPositions":[10,16.25,22.5,28.75,35],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Dec<br/>2025","6":"Mar<br/>2026","9":"Jun<br/>2026","12":"Sep<br/>2026","25":"Sep<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,24.6,25.39252273846154,26.18504547692308,26.977568215384615,27.770090953846154,28.562613692307693,29.35513643076923,30.14765916923077,30.940181907692306,31.732704646153845,32.525227384615384,33.31775012307692,34.11027286153846,{"y":34.9027956,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,24.6,25.079292521538463,25.558585043076924,26.037877564615385,26.51717008615385,26.99646260769231,27.475755129230773,27.955047650769234,28.434340172307696,28.91363269384616,29.392925215384622,29.872217736923083,30.351510258461545,{"y":30.830802780000006,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,24.6,24.72131513076923,24.842630261538464,24.963945392307693,25.085260523076926,25.206575653846155,25.327890784615384,25.449205915384617,25.570521046153846,25.691836176923076,25.81315130769231,25.934466438461538,26.05578156923077,{"y":26.1770967,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":19.6,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":21,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.6,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.3,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.5,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.2,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.1,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":20.8,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.8,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":20.2,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":27.2,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":25.4,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":24.6,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€34.90Average Price Target€30.83Lowest Price Target€26.18
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Jefferies Analyst forecast on IT:1ACHC
Brian Tanquilut
Jefferies
Jefferies
€34.9
Buy
41.88%
Upside
Reiterated
09/17/26
Analysts Offer Insights on Healthcare Companies: Oscar Health (NYSE: OSCR) and Acadia Healthcare (NASDAQ: ACHC)
Bank of America Securities Analyst forecast on IT:1ACHC
Joanna Gajuk
Bank of America Securities
Bank of America Securities
―
Sell
―
Reiterated
09/14/26
Analysts Offer Insights on Healthcare Companies: Acadia Healthcare (NASDAQ: ACHC) and Zentek (Other OTC: ZTEKF)
Barclays Analyst forecast on IT:1ACHC
Andrew Mok CFA
Barclays
Barclays
€27.92
Hold
13.51%
Upside
Reiterated
08/28/26
Barclays Remains a Hold on Acadia Healthcare (ACHC)
RBC Capital Analyst forecast on IT:1ACHC
Ben Hendrix
RBC Capital
RBC Capital
€27.05
Buy
9.96%
Upside
Reiterated
07/30/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Humana (NYSE: HUM), Boston Scientific (NYSE: BSX) and Acadia Healthcare (NASDAQ: ACHC)
KeyBanc Analyst forecast on IT:1ACHC
Matthew Gillmor CFA
KeyBanc
KeyBanc
€34.9
Buy
41.88%
Upside
Reiterated
07/30/26
KeyBanc Keeps Their Buy Rating on Acadia Healthcare (ACHC)
TD Cowen Analyst forecast on IT:1ACHC
Ryan Langston
TD Cowen
TD Cowen
€31.41
Buy
27.69%
Upside
Reiterated
07/30/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Avantor (NYSE: AVTR) and Acadia Healthcare (NASDAQ: ACHC)
Cantor Fitzgerald Analyst forecast on IT:1ACHC
Sarah James
Cantor Fitzgerald
Cantor Fitzgerald
€26.18
Hold
6.41%
Upside
Reiterated
07/29/26
Acadia Healthcare's PLGL headwind offsets DPP benefit, says Cantor FitzgeraldAcadia Healthcare's PLGL headwind offsets DPP benefit, says Cantor Fitzgerald
Guggenheim Analyst forecast on IT:1ACHC
Jason Cassorla
Guggenheim
Guggenheim
€33.16→€34.03
Buy
38.33%
Upside
Reiterated
07/29/26
Guggenheim Sticks to Its Buy Rating for Acadia Healthcare (ACHC)
UBS Analyst forecast on IT:1ACHC
A.J. Rice
UBS
UBS
€34.03
Buy
38.33%
Upside
Reiterated
07/28/26
Acadia Healthcare: Solid Operating Trends, Raised 2026 Guidance, and Buy Rating Reiterated with Price Target Maintained at $39
Mizuho Securities Analyst forecast on IT:1ACHC
Ann Hynes
Mizuho Securities
Mizuho Securities
€23.56→€27.05
Hold
9.96%
Upside
Reiterated
07/13/26
Mizuho Securities Remains a Hold on Acadia Healthcare (ACHC)
Raymond James Analyst forecast on IT:1ACHC
John Ransom
Raymond James
Raymond James
€21.81→€34.03
Buy
38.33%
Upside
Reiterated
05/04/26
Acadia Healthcare upgraded to Strong Buy from Outperform at Raymond JamesAcadia Healthcare upgraded to Strong Buy from Outperform at Raymond James
Deutsche Bank Analyst forecast on IT:1ACHC
Pito Chickering
Deutsche Bank
Deutsche Bank
€22.69→€27.92
Buy
13.51%
Upside
Reiterated
05/01/26
Acadia Healthcare price target raised to $32 from $26 at Deutsche BankAcadia Healthcare price target raised to $32 from $26 at Deutsche Bank
Leerink Partners Analyst forecast on IT:1ACHC
Whit Mayo
Leerink Partners
Leerink Partners
€12.22
Hold
-50.34%
Downside
Downgraded
12/03/25
Acadia Healthcare downgraded to Market Perform from Outperform at LeerinkAcadia Healthcare downgraded to Market Perform from Outperform at Leerink
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Jefferies Analyst forecast on IT:1ACHC
Brian Tanquilut
Jefferies
Jefferies
€34.9
Buy
41.88%
Upside
Reiterated
09/17/26
Analysts Offer Insights on Healthcare Companies: Oscar Health (NYSE: OSCR) and Acadia Healthcare (NASDAQ: ACHC)
Bank of America Securities Analyst forecast on IT:1ACHC
Joanna Gajuk
Bank of America Securities
Bank of America Securities
―
Sell
―
Reiterated
09/14/26
Analysts Offer Insights on Healthcare Companies: Acadia Healthcare (NASDAQ: ACHC) and Zentek (Other OTC: ZTEKF)
Barclays Analyst forecast on IT:1ACHC
Andrew Mok CFA
Barclays
Barclays
€27.92
Hold
13.51%
Upside
Reiterated
08/28/26
Barclays Remains a Hold on Acadia Healthcare (ACHC)
RBC Capital Analyst forecast on IT:1ACHC
Ben Hendrix
RBC Capital
RBC Capital
€27.05
Buy
9.96%
Upside
Reiterated
07/30/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Humana (NYSE: HUM), Boston Scientific (NYSE: BSX) and Acadia Healthcare (NASDAQ: ACHC)
KeyBanc Analyst forecast on IT:1ACHC
Matthew Gillmor CFA
KeyBanc
KeyBanc
€34.9
Buy
41.88%
Upside
Reiterated
07/30/26
KeyBanc Keeps Their Buy Rating on Acadia Healthcare (ACHC)
TD Cowen Analyst forecast on IT:1ACHC
Ryan Langston
TD Cowen
TD Cowen
€31.41
Buy
27.69%
Upside
Reiterated
07/30/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Avantor (NYSE: AVTR) and Acadia Healthcare (NASDAQ: ACHC)
Cantor Fitzgerald Analyst forecast on IT:1ACHC
Sarah James
Cantor Fitzgerald
Cantor Fitzgerald
€26.18
Hold
6.41%
Upside
Reiterated
07/29/26
Acadia Healthcare's PLGL headwind offsets DPP benefit, says Cantor FitzgeraldAcadia Healthcare's PLGL headwind offsets DPP benefit, says Cantor Fitzgerald
Guggenheim Analyst forecast on IT:1ACHC
Jason Cassorla
Guggenheim
Guggenheim
€33.16→€34.03
Buy
38.33%
Upside
Reiterated
07/29/26
Guggenheim Sticks to Its Buy Rating for Acadia Healthcare (ACHC)
UBS Analyst forecast on IT:1ACHC
A.J. Rice
UBS
UBS
€34.03
Buy
38.33%
Upside
Reiterated
07/28/26
Acadia Healthcare: Solid Operating Trends, Raised 2026 Guidance, and Buy Rating Reiterated with Price Target Maintained at $39
Mizuho Securities Analyst forecast on IT:1ACHC
Ann Hynes
Mizuho Securities
Mizuho Securities
€23.56→€27.05
Hold
9.96%
Upside
Reiterated
07/13/26
Mizuho Securities Remains a Hold on Acadia Healthcare (ACHC)
Raymond James Analyst forecast on IT:1ACHC
John Ransom
Raymond James
Raymond James
€21.81→€34.03
Buy
38.33%
Upside
Reiterated
05/04/26
Acadia Healthcare upgraded to Strong Buy from Outperform at Raymond JamesAcadia Healthcare upgraded to Strong Buy from Outperform at Raymond James
Deutsche Bank Analyst forecast on IT:1ACHC
Pito Chickering
Deutsche Bank
Deutsche Bank
€22.69→€27.92
Buy
13.51%
Upside
Reiterated
05/01/26
Acadia Healthcare price target raised to $32 from $26 at Deutsche BankAcadia Healthcare price target raised to $32 from $26 at Deutsche Bank
Leerink Partners Analyst forecast on IT:1ACHC
Whit Mayo
Leerink Partners
Leerink Partners
€12.22
Hold
-50.34%
Downside
Downgraded
12/03/25
Acadia Healthcare downgraded to Market Perform from Outperform at LeerinkAcadia Healthcare downgraded to Market Perform from Outperform at Leerink
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
LGNDLigand Pharma
DNLIDenali Therapeutics
ACHVAchieve Life Sciences
PMNProMIS Neurosciences
CELCCelcuity
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Acadia Healthcare

3 Months
Brian TanquilutJefferies
Success Rate
21/36 ratings generated profit
58%
Average Return
-1.75%
Copying Brian Tanquilut's trades and holding each position for 3 Months would result in 58.33% of your transactions generating a profit, with an average return of -1.75% per trade.
1 Year
John RansomRaymond James
Success Rate
17/38 ratings generated profit
45%
Average Return
+9.10%
Copying John Ransom's trades and holding each position for 1 Year would result in 44.74% of your transactions generating a profit, with an average return of +9.10% per trade.
2 Years
John RansomRaymond James
Success Rate
20/38 ratings generated profit
53%
Average Return
+21.58%
Copying John Ransom's trades and holding each position for 2 Years would result in 52.63% of your transactions generating a profit, with an average return of +21.58% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

1ACHC Analyst Recommendation Trends

Rating
May 26
Jun 26
Jul 26
Aug 26
Sep 26
Strong Buy
0
0
0
0
0
Buy
7
8
14
10
10
Hold
7
6
7
5
5
Sell
1
1
1
1
2
Strong Sell
0
0
0
0
0
total
15
15
22
16
17
In the current month, 1ACHC has received 10 Buy Ratings, 5 Hold Ratings, and 2 Sell Ratings. 1ACHC average Analyst price target in the past 3 months is 30.83.
Each month's total comprises the sum of three months' worth of ratings.

1ACHC Financial Forecast

1ACHC Earnings Forecast

Next quarter’s earnings estimate for 1ACHC is €0.41 with a range of €0.34 to €0.48. The previous quarter’s EPS was €0.33. 1ACHC beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year 1ACHC has Performed in-line its overall industry.
Next quarter’s earnings estimate for 1ACHC is €0.41 with a range of €0.34 to €0.48. The previous quarter’s EPS was €0.33. 1ACHC beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year 1ACHC has Performed in-line its overall industry.

1ACHC Sales Forecast

Next quarter’s sales forecast for 1ACHC is €761.17M with a range of €754.87M to €771.40M. The previous quarter’s sales results were €750.79M. 1ACHC beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year 1ACHC has Performed in-line its overall industry.
Next quarter’s sales forecast for 1ACHC is €761.17M with a range of €754.87M to €771.40M. The previous quarter’s sales results were €750.79M. 1ACHC beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year 1ACHC has Performed in-line its overall industry.

1ACHC Stock Forecast FAQ

What is IT:1ACHC’s average 12-month price target, according to analysts?
Based on analyst ratings, Acadia Healthcare’s 12-month average price target is 30.83.
    What is IT:1ACHC’s upside potential, based on the analysts’ average price target?
    Acadia Healthcare has 25.33% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Acadia Healthcare a Buy, Sell or Hold?
          Acadia Healthcare has a consensus rating of Moderate Buy, which is based on 6 buy ratings, 3 hold ratings and 1 sell ratings.
            What is Acadia Healthcare’s share price target?
            The average share price target for Acadia Healthcare is 30.83. This is based on 10 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is €34.90 ,and the lowest forecast is €26.18. The average share price target represents 25.33% Increase from the current price of €24.6.
              What do analysts say about Acadia Healthcare?
              Acadia Healthcare’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 10 Wall Streets Analysts.
                How can I buy shares of Acadia Healthcare?
                To buy shares of IT:1ACHC, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.